Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Mechanisms involved in the antinociceptive and anti-inflammatory effects of a new triazole derivative: 5-[1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl]-1H-tetrazole (LQFM-096)

  • 31 Accesses


The aim of this study was to design, synthesize and evaluate the potential analgesic and anti-inflammatory effects of 5-[1-(4-fluorphenyl)-1H-1,2,3-triazol-4-yl]-1H-tetrazole—(LQFM-096: a new triazole compound) as well as to elucidate its possible mechanisms of action. The oral administration of LQFM-096 (10, 20 or 40 mg/kg) decreased the number of writhing in mice. At the dose of 20 mg/kg, LQFM-096 reduced the licking time at both neurogenic and inflammatory phases of the formalin test. Pretreatment with naloxone (3 mg/kg) and glibenclamide (3 mg/kg) attenuated the antinociceptive effect of LQFM-096 in the first phase of the formalin test. At the dose of 20 mg/kg, LQFM-096 also decreased the licking time in the acidified saline-induced and capsaicin-induced nociception. This effect was blocked by naloxone (3 mg/kg) pretreatment prior to the administration of LQFM-096. In addition, LQFM-096 inhibited hyperalgesia induced by carrageenan and PGE2. Naloxone (3 mg/kg) attenuated the effect of LQFM-096 through disinhibition of PGE2-induced hyperalgesia. The anti-inflammatory effect of LQFM-096 was demonstrated in carrageenan-induced oedema or pleurisy as well as CFA-induced arthritis. The hyperalgesia and cellular migration in CFA-induced arthritis were reduced significantly. Altogether, these findings suggest antinociceptive effect of LQFM-096 and implicate the modulation of ASICs/TRPV1 channels by opioid/KATP pathway. The anti-inflammatory effect of LQFM-096 was mediated by a reduction in oedema, leukocytes migration, TNF-α, PGE2 levels and myeloperoxidase activity.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10


  1. Alterman M, Hallberg A (2000) Fast microwave-assisted preparation of aryl and vinyl nitriles and the corresponding tetrazoles from organo-halides. J Org Chem 65(23):7984–7989. https://doi.org/10.1021/jo0009954

  2. Anseloni VCZ, Ennis M, Lidow MS (2003) Optimization of the mechanical nociceptive threshold testing with the Randall-Selitto assay. J Neurosci Met 13:93–97. https://doi.org/10.1016/S0165-0270(03)00241-3

  3. Baggio CH, Freitas CS, Marcon R, Werner MF, Rae GA et al (2012) Antinociception of b-d-glucan from Pleurotus pulmuonarius is possible related to protein kinaseinhibition. Int Biol Macromol 50:872–877

  4. Barbosa FL, Mori LS, Riva D, Stefanello MÉ, Zampronio AR (2013) Antinociceptive and anti-inflammatory activities of the ethanolic extract, fractions and 8-methoxylapachenol from Sinningia allagophylla tubers. Basic Clin Pharmacol Toxicol 113:1–7

  5. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R et al (2008) Opioid complications and side effects. Pain Physician 11:S105–S120

  6. Cai Q, Qiu C, Qiu F, Liu T, Qu Z et al (2014) Morphine inhibits acid-sensing ion channel currents in rat dorsal root ganglion neurons. Brain Res 1554:12–20. https://doi.org/10.1016/j.brainres.2014.01.042

  7. Campbell VC, Welch SP (2001) The role of minoxidil on endogenous opioid peptides in the spinal cord: a putative co-agonist relationship between K-ATP openers and opioids. Eur J Pharmacol 417(1–2):91–98

  8. Chandy RL, Moore PK (1998) Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia. Neuropharmacology 37(1):37–43

  9. Chopade AR, Sayyad FJ (2013) Antinociceptive effect of Phyllanthus fraternus extract in complete Freund’s adjuvant induced chronic pain in mice. Biomed Aging Pathol 3:235–240

  10. Costa EA, Lino RC, Gomes MN, Nascimento MNM, Florentino IF et al (2013) Anti-inflammatory and antinociceptive activities of LQFM 002—a 4-nerolidylcatechol derivate. Life Sci 92:237–244. https://doi.org/10.1016/j.lfs.2012.12.003

  11. Deval E, Lingueglia E (2015) Acid-sensing ion channels and nociception in the peripheral and central nervous systems. Neuropharmacology 94:49–57. https://doi.org/10.1016/j.neuropharm.2015.02.009

  12. Deval E, Gasull X, Noël J, Salinas M, Baron A et al (2010) Acid-sensing ion channels (ASICs): pharmacology and implication in pain. Pharmacol Ther 128:549–558. https://doi.org/10.1016/j.pharmthera.2010.08.006

  13. Dheer D, Singh V, Shankar R (2017) Medicinal attributes of 1,2,3-triazoles: current developments. Bioorg Chem 71:30–54

  14. Di Rosa M (1972) Biological properties of carrageenan. J Pharmacol 24(2):89–102

  15. Endres-Becker J, Heppenstall PA, Mousa SA, Labuz D, Oksche A et al (2007) Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol Pharmacol 71:12–18. https://doi.org/10.1124/mol.106.026740

  16. Fein A (2011) Nociceptores: as células que sentem dor. Tradução de PETROV, P.; FRANCISCHI, J. N.; FERREIRA, S. H. Ribeirão Preto/SP. 2011. Disponível em: http://cell.uchc.edu/pdf/fein/nociceptors_fein_2012.pdf

  17. Florentino IF, Silva DPB, Silva DM, Cardoso CS, Moreira ALE, Borges CL, Soares CMA, Galdino PM, Lião LM, Ghedini PC, Menegatti R, Costa EA (2017) Potential anti-inflammatory effect of LQFM-021 in carrageenan-induced inflammation: the role of nitric oxide. Nitric Oxide 69:35–44. https://doi.org/10.1016/j.niox.2017.04.006

  18. Giorno TBS, Da Silva BV, Pinto AC, Fernandes PD (2016) Antinociceptive effect and mechanismof action of isatin, N-methyl isatin and oxopropyl isatin in mice. Life Sci 15:189–198

  19. Gold MS, Gebhart GF (2010) Nociceptor sensitization in pain pathogenesis. Nat Med 16(11):1248–1257. https://doi.org/10.1038/nm.2235

  20. Gregory N, Harris AL, Robinson CR, Dougherty PM, Fuchs PN, Sluka KA (2013) An overview of animal models of pain: disease models and outcome measures. J Pain 14(11):1255–1269

  21. Gupta D, Jain DK (2017) Synthesis, antifungal and antibacterial activity of novel 1,2,4-triazole derivatives. J Adv Pharm Technol Res. 6:141–146. https://doi.org/10.4103/2231-4040.161515

  22. Haegens A, Heeringa P, Suylen RJV, Steele C, Aratani Y et al (2009) Myeloperoxidase deficiency attenuates Lipopolysaccharide-induced acute lung inflammation and subsequent citokyne and chemokine production. J Immunol 182(12):7990–7996

  23. Hagmann WK (2008) The many roles for fluorine in medicinal chemistry. J Med Chem 51:4359–4369. https://doi.org/10.1021/jm800219f

  24. Hanskaar S, Hole K (1987) The formalin test in mice: dissociation between in- flammatory and non-inflammatory pain. J Pain. 30(1):103–114. https://doi.org/10.1016/0304-3959(87)90088-1

  25. http://www.iasp-pain.org/Taxonomy. Pain terms, a current list with definitions and notes on usage (pp 209–214). Classification of Chronic Pain, Second Edition, IASP Task Force on Taxonomy, edited by H. Merskey and N. Bogduk, IASP Press, Seattle, ©1994

  26. Hunashal RD, Ronad PM, Maddi VS, Satyanarayana D, Kamadod MA (2014) Synthesis, anti-inflammatory and analgesic activity of 2-[4-(substituted benzylideneamino)-5-(substituted phenoxymethyl)-4H-1,2,4-triazol-3-ylthio] acetic acid derivatives. Arab J Chem 7(6):1070–1078. https://doi.org/10.1016/j.arabjc.2011.01.003

  27. Jage J (2005) Opioid tolerance and dependence. Do they matter?. Eur J Pain 9:157–162. https://doi.org/10.1016/j.ejpain.2004.11.009

  28. Ji RR, Xu ZZ, Gao YJ (2014) Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov 13:533–538. https://doi.org/10.1038/nrd4334

  29. Joanna L, Talarek S, Orzelska J, Fidecka S, Wujec M, Plech T (2014) The antinociceptive effect of 4-substituted derivatives of 5-(4-chlorophenyl)-2-(morpholin-4-ylmethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione in mice. Naunyn-Schmiedeberg’s Arch Pharmacol 387:367–375. https://doi.org/10.1007/s00210-013-0938-0

  30. Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413:203–210. https://doi.org/10.1038/35093019

  31. Kawabata A (2001) Prostaglandin E2 and pain—an update. Biol Pharm Bull 34(8):1170–1173

  32. Khanage SG, Raju A, Mohite PB, Pandhare RB (2013) Analgesic activity of some 1,2,4-triazole heterocycles clubbed with pyrazole, tetrazole, isoxazole and pyrimidine. Adv Pharm Bull 3(1):13–18. https://doi.org/10.5681/apb.2013.003

  33. Klebanoff SJ (2005) Myeloperoxidase: a friend and foe. J Leuk Biol 77:598–625

  34. Koster R, Anderson M, De Beer EJ (1959) Acetic acid for analgesic screening. Fed Proc 18:412

  35. L’abbé G, Bruynseels M, Delbeke P, Topper S (1990) Molecular rearrangements of 4-iminomethyl-1,2,3-triazoles replacement of 1-aryl substituents in 1H-1,2,3-triazoles-4-carbaldehydes. J Heterocycl Chem 27:2021

  36. Li J, Zhang J, Rodrigues MC, Ding D, Longo JPF et al (2016) Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity. Bioorg Med Chem Lett 26(16):3881–3885. https://doi.org/10.1016/j.bmcl.2016.07.017

  37. Lima LM, Barreiro EJ (2005) Bioisosterism: a useful strategy for molecular modification and drug design. Curr Med Chem 12:23–49

  38. Ma W, Quirion R (2007) Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets 11(3):307–320

  39. Meotti FC, Coelho IS, Santos ARS (2010) The nociception induced by glutamate in mice is potentiated by protons released into solution. J Pain 11(6):570–578. https://doi.org/10.1016/j.jpain.2009.09.012

  40. Mickle AD, Shepherd AJ, Mohapatra DP (2016) Nociceptive TRP channels: sensory detectors and transducers in multiple pain pathologies. J Pharm 9:72. https://doi.org/10.3390/ph9040072

  41. Mohd Sani MH, Zakaria ZA, Balan T, The LK, Salleh MZ (2012) Antinociceptive activity of methanol extract of Muntingia calabura leaves and the mechanisms of action involved. J Evid Based Complement Altern Med 2012:1–10. https://doi.org/10.1155/2012/890361

  42. Montes GC, Silva BNM, Rezende B, Sudo RT, Ferreira VF (2017) The hypnotic, anxiolytic, and antinociceptive profile of a novel μ-opioid agonist. Molecules 22:800. https://doi.org/10.3390/molecules22050800

  43. Moore AR (2003) Pleural models of inflammation: immune and noimmune. In: Winyard PG, Willoughby DA (eds) Inflammation protocols. Humana Press, Totowa, pp 123–128

  44. Nourshargh S, Alon R (2014) Leukocyte migration into inflamed tissues. Immunity. https://doi.org/10.1016/j.immuni.2014.10.008

  45. Oliveira LP, Silva DPB, Florentino IF, Fajemiroye JO, Oliveira TS et al (2016) New pyrazole derivative 5-[1-(4-fluorophenyl)-1H-pyrazol-4-yl]-2H-tetrazole:synthesis and assessment of some biological activities. Chem Biol Drug Des. https://doi.org/10.1111/cbdd.12838

  46. Oliveira-Junior JO, Portela Junior CSA, Cohen CP (2016) Inflammatory mediators of neuropathic pain. Sociedade Brasileira para o Estudo da Dor 17(Suppl 1):S35–S42. https://doi.org/10.5935/1806-0013.20160045

  47. Passos GF, Fernandes ES, da Cunha FM, Ferreira J, Pianowski LF et al (2007) Anti-inflammatory and anti-allergic properties of the essential oil and active compounds from Cordia verbenacea. J Ethnopharmacol 110(2):323–333

  48. Peng Y, Zhang Q, Arora S, Keenan SM, Kortagere S et al (2009) Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways. Bioorg Med Chem 17:6442–6450. https://doi.org/10.1016/j.bmc.2009.07.007

  49. Penthala NR, Madhukuri L, Thakkar S, Madadi NR, Lamture G et al (2015) Synthesis and anti-cancer screening of novel heterocyclic-IJ2H)-1,2,3-triazoles as potential anticancer agents. Med Chem Commun J 6:1535–1543. https://doi.org/10.1039/C5MD00219B

  50. Porreca F, Ossipov MH (2009) Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options. Pain Med 10(4):654–662. https://doi.org/10.1111/j.1526-4637.2009.00583.x

  51. Portman R (1998) WO Patent 9802423

  52. Rajkapoor B, Kavimani S, Ravichandiran V, Sekhar K, Senthil Kumar R et al (2009) Effect of Indigofera aspalathoides on complete Freund’s adjuvant-induced arthritis in rats. Pharm Biol 47(6):553–557. https://doi.org/10.1080/13880200902902489

  53. Randall LO, Selitto JJ (1957) A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Thér 4:409–419

  54. Rios ERV, Rocha NFM, Carvalho AMR, Vanconcelos LF, Dias ML et al (2013) TRP and ASIC channels mediate the antinociceptive effect of citronellyl acetate. Chem Biol Interact 203:573–579. https://doi.org/10.1016/j.cbi.2013.03.014

  55. Roschangar F, Sheldon RA, Senanayake CH (2015) Overcoming barriers to green chemistry in the pharmaceutical industry—the Green Aspiration LevelTM concept. Green Chem 17:752–758. https://doi.org/10.1039/c4gc01563k

  56. Sakurada T, Katsumata K, Tan-No K, Sakurada S, Kisara K (1992) The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacol J 31:1279–1285

  57. Saleh TSF, Calixto JB, Medeiros YS (1999) Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides 20(8):949–956

  58. Sedgwick AD (1995) Initiation of inflammatory response and its prevention. In: Bonta IL, Bray MA (eds) EUA: handbook of inflammation. Elsevier, New York, p 253

  59. Sehgal N, Smith H, Manchikanti L (2011) Peripherally acting opioids and clinical implications for pain control. Pain Physician 14:249–258

  60. Shibata M, Ohkubo T, Takahashi H, Inoki R (1989) Modified formalin test: characteristic biphasic pain response. Pain 38(3):347–352

  61. Sokal RR, Rohlf FJ (1981) Biometry: the principles and practice of statistics in biological research. W.H. Freeman and Co., New York

  62. Trost BM (1991) The atom economy–a search for synthetic efficiency. Science 254:1471

  63. Tsuchida K, Ibuki T, Matsumura K (2015) Bromoenol lactone, an inhibitor of calcium-independent phospholipase A2, suppresses carrageenan-induced prostaglandin production and hyperalgesia in rat hind paw. Mediators Inflamm 2015:1–7. https://doi.org/10.1155/2015/605727

  64. Vijayalaxmi A, Bakshi V, Begum N, Kowmudi V, Naveen Kumar NY, Reddy Y (2015) Anti-arthritic and anti inflammatory activity of beta caryophyllene against Freund’s complete adjuvant induced arthritis in wistar rats. Bone Rep Recomm 1:29. https://doi.org/10.4172/2469-6684.10009

  65. Wang J, Sánchez-Roselló M, Aceña JL, del Pozo C, Sorochinsky AE et al (2014) Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001–2011). Chem Rev 114:2432–2506. https://doi.org/10.1021/cr4002879

  66. Watanabe M, Ueda T, Shibata Y, Kumamoto N, Ugawa S (2015) The role of TRPV1 channels in carrageenan-induced mechanical hyperalgesia in mice. NeuroReport 26(3):173–178

  67. Wemmie JA, Taugher RJ, Kreple CJ (2013) Acid-sensing ion channels in pain and disease. Nat Rev Neurosci 14(7):461–471. https://doi.org/10.1038/nrn3529

  68. White JPM, Cibelli M, Fidalgo AR (2010) Role of transient receptor potential and acid-sensing ion channels in peripheral inflammatory pain. Anesthesiology 112:729–741

  69. Yet L (2018) Privileged structures in drug discovery medicinal chemistry and synthesis, 1st edn. Wiley, Hoboken

  70. Zelová H, Hosek J (2013) TNF-a signalling and inflammation: interactions between old acquaintances. Inflamm Res 62:641–651. https://doi.org/10.1007/s00011-013-0633-0

  71. Zwaagstra ME, Timmerman H, Tamura M, Tohma T, Wada Y et al (1997) Synthesis and structure-activity relationships of carboxylated chalcones: a novel series of CysLT1 (LTD4) receptor antagonists. J Med Chem 40(7):1075–1089. https://doi.org/10.1021/jm960628d

Download references


The authors are grateful to Dr. Ekaterina A. F. B. Rivera, Lucas B. do Nascimento and Taís Andrade Dias de Souza for ethical and technical assistance, as well as the CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico), and CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) for financial support.

Author information

Correspondence to Elson A. Costa.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 986 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cardoso, C.S., Silva, D.P.B., Silva, D.M. et al. Mechanisms involved in the antinociceptive and anti-inflammatory effects of a new triazole derivative: 5-[1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl]-1H-tetrazole (LQFM-096). Inflammopharmacol (2020). https://doi.org/10.1007/s10787-020-00685-8

Download citation


  • Pain
  • Inflammation
  • Opioid receptors
  • ASICs
  • TRPV1
  • TNF-α